These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9611714)

  • 1. [Quantification of HIV-1 viral load by the measurement of reverse transcriptase activity].
    García Lerma JG; Heneine W
    Med Clin (Barc); 1998 Apr; 110(12):453-4. PubMed ID: 9611714
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantification of human immunodeficiency virus type 1 by reverse transcriptase-coupled polymerase chain reaction.
    Kuritzkes DR
    J Infect Dis; 2004 Dec; 190(11):2047-54. PubMed ID: 15529271
    [No Abstract]   [Full Text] [Related]  

  • 3. Improved conditions for extraction and amplification of human immunodeficiency virus type 1 RNA from plasma samples with low viral load.
    Villahermosa ML; Thomson M; Vázquez de Parga E; Cuevas MT; Contreras G; Pérez-Alvarez L; Delgado E; Manjón N; Medrano L; Nájera R
    J Hum Virol; 2000; 3(1):27-34. PubMed ID: 10774804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [HIV quantification--how and why].
    Katzenstein TL; Pedersen C; Gerstoft J
    Ugeskr Laeger; 1997 Dec; 160(1):18-24. PubMed ID: 9446260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical comparison of branched DNA and reverse transcriptase-PCR and nucleic acid sequence-based amplification assay for the quantitation of circulating recombinant form_BC HIV-1 RNA in plasma.
    Pan P; Tao X; Zhang Q; Xing W; Sun X; Pei L; Jiang Y
    AIDS; 2007 Dec; 21 Suppl 8():S27-32. PubMed ID: 18172387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health care industries' perspective of viral load assays: the VERSANT HIV-1 RNA 3.0 assay.
    Elbeik T; Loftus RA; Beringer S
    Expert Rev Mol Diagn; 2002 May; 2(3):275-85. PubMed ID: 12050866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance.
    Steegen K; Demecheleer E; De Cabooter N; Nges D; Temmerman M; Ndumbe P; Mandaliya K; Plum J; Verhofstede C
    J Virol Methods; 2006 May; 133(2):137-45. PubMed ID: 16375980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of HIV-1 RNA load by one-tube-one-step RT PCR and real time PCR assay with TaqMan probe.
    Watanaveeradej V; Sirirattanaphoomee S; Chantratita W; Nitayaphan S; Viputtikul K; Kerdpanich A; Samakoses R; Simasathien S
    J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S206-13. PubMed ID: 16858960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of human immunodeficiency virus type 1 viral load in plasma using reverse transcriptase activity assay at a district hospital laboratory in Botswana: a decentralization pilot study.
    Mine M; Bedi K; Maruta T; Madziva D; Tau M; Zana T; Gaolathe T; Moyo S; Seipone K; Ndwapi N; Essex M; Marlink R
    J Virol Methods; 2009 Jul; 159(1):93-7. PubMed ID: 19442851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevation of viral load by PCR and use of plasma preparation tubes for quantification of human immunodeficiency virus type 1.
    García-Bujalance S; Ladrón de Guevara C; González-García J; Arribas JR; Zamora F; Gutiérrez A
    J Microbiol Methods; 2007 May; 69(2):384-6. PubMed ID: 17363096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 and HCV viral load cost models for bDNA: 440 Molecular System versus real-time PCR AmpliPrep/TaqMan test.
    Elbeik T; Dalessandro R; Loftus RA; Beringer S
    Expert Rev Mol Diagn; 2007 Nov; 7(6):723-53. PubMed ID: 18020903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New test for determination of HIV-1 RNA level].
    Dtsch Med Wochenschr; 2003 Aug; 128(31-32):1680. PubMed ID: 12931729
    [No Abstract]   [Full Text] [Related]  

  • 13. Lowering the detection limits of HIV-1 viral load using real-time immuno-PCR for HIV-1 p24 antigen.
    Barletta JM; Edelman DC; Constantine NT
    Am J Clin Pathol; 2004 Jul; 122(1):20-7. PubMed ID: 15272526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful use of genotypic resistance testing in HIV-1-infected individuals with detectable viraemia between 50 and 1000 copies/ml.
    Waters L; Mandalia S; Asboe D
    AIDS; 2006 Mar; 20(5):778-9. PubMed ID: 16514311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The measurement of HIV-1 viral load in resource-limited settings: how and where?
    Rouet F; Rouzioux C
    Clin Lab; 2007; 53(3-4):135-48. PubMed ID: 17447649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of infectious HIV-1 plasma viral load using a boosted in vitro infection protocol.
    Rusert P; Fischer M; Joos B; Leemann C; Kuster H; Flepp M; Bonhoeffer S; Günthard HF; Trkola A
    Virology; 2004 Aug; 326(1):113-29. PubMed ID: 15262500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Viral load quantification for the early diagnosis of perinatal human immunodeficiency virus 1 (HIV-1) infection].
    Resino García S; Alonso Arias R; Jiménez Fuentes JL; Gurbindo Gutiérrez D; Muñoz-Fernández MA
    An Esp Pediatr; 1998 Jul; 49(1):60-4. PubMed ID: 9718769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examination of real-time PCR for HIV-1 RNA and DNA quantitation in patients infected with HIV-1 BF intersubtype recombinant variants.
    Schvachsa N; Turk G; Burgard M; Dilernia D; Carobene M; Pippo M; Gómez-Carrillo M; Rouzioux C; Salomon H
    J Virol Methods; 2007 Mar; 140(1-2):222-7. PubMed ID: 17166599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletions in the beta3-beta4 hairpin loop of HIV-1 reverse transcriptase are observed in HIV-1 isolated from subjects during long-term antiretroviral therapy.
    Ross L; Johnson M; Ferris RG; Short SA; Boone LR; Melby TE; Lanier R; Shaefer M; St Clair M
    J Hum Virol; 2000; 3(3):144-9. PubMed ID: 10881994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations linked to drug resistance, human immunodeficiency virus type 1 biologic phenotype and their association with disease progression in children receiving nucleoside reverse transcriptase inhibitors.
    Englund JA; Raskino C; Vavro C; Palumbo P; Ross LL; McKinney R; Nikolic-Djokic D; Colgrove RC; Baker CJ;
    Pediatr Infect Dis J; 2004 Jan; 23(1):15-22. PubMed ID: 14743040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.